Ben H. Chew¹, Bodo E. Knudsen¹, Madeleine Moussa², Stephen E. Pautler¹

Canadian Journal of Urology, Vol.12, No.1, pp. 2555-2556, 2005

Abstract There are less than 100 cases of retroperitoneal schwannoma reported in the world literature. These are differentiated from gastrointestinal schwannomas found in the gastrointestinal tract. A case of a rare retroperitoneal gastrointestinal schwannoma presenting as a perinephric tumor is described. Treatment of such masses is local excision and final diagnosis is from histopathology. More >

Stephen Lazarou, Sender Herschorn

Canadian Journal of Urology, Vol.12, No.1, pp. 2553-2554, 2005

Abstract To our knowledge, there have been no reported cases of ureteric obstruction resulting in a non-functioning hydronephrotic kidney after uterine fibroid embolization. We report a case of a patient who required surgical intervention for management of symptoms. More >

Richard Choo^1,2, Sarat Chander^1,3, Cyril Danjoux¹, Gerard Morton¹, Andrew Pearce¹, Gerrit Deboer¹, Ewa Szumacher¹, Andrew Loblaw¹, Patrick Cheung¹, Tony Woo¹

Canadian Journal of Urology, Vol.12, No.1, pp. 2547-2552, 2005

Abstract Purpose: To examine the change of hemoglobin in relation to testosterone level in non-metastatic prostate cancer patients receiving 2-year androgen suppression.
Methods and materials: A cohort of 72 patients, as participants of a phase II study, were treated with adjuvant radiotherapy plus 2-year androgen suppression after surgery to reduce the risk of relapse. Patients had laboratory tests including hemoglobin (Hb) and testosterone, and a quality of life questionnaire at regular intervals during the androgen suppression and post-androgen suppression period. The pattern of the change in Hb was evaluated in relation to testosterone level. The clinical significance of… More >

S. Hajebrahimi^*, W. Altaweel, J. Cadoret, E. Cohen, J. Corcos

Canadian Journal of Urology, Vol.12, No.1, pp. 2543-2546, 2005

Abstract Introduction and objectives: To study the effects of intradetrusor botulinum-A toxin (BTA) (BOTOX®) injections in adult patients with detrusor overactivity who failed to respond to anticholinergic medications or developed intolerable side-effects.
Materials and methods: Ten patients (average age 41 years, range 19-76 years) with neurogenic bladder and detrusor overactivity who were using clean intermittent catheterization 4 to 7 times a day with anticholinergic therapy were included in our study. Their history, physical examination, abdominal ultrasound, urine analysis, serum creatinine and electrolytes, as well as multichannel urodynamic evaluation were documented before administration of BTA injections. Anticholinergic medication was stopped… More >

Alvaro Ramirez¹, Paul Perrotte¹, Luc Valiquette¹, Francois Benard¹, Mike McCormack¹, Fred Saad¹, Caroline Fournier¹, Shahrokh Shariat², Pierre I. Karakiewicz¹

Canadian Journal of Urology, Vol.12, No.1, pp. 2537-2542, 2005

Abstract Objectives: We explored the specific impact of urinary diversion type on HRQOL in men after cystectomy for bladder cancer. Our intent was to provide a basis for the development of a diversion-specific instrument.
Methods: We invited 13 ileal conduit and 12 orthotopic urinary diversion (neo-bladder) male patients to several open-ended interviews. We explored HRQOL domains that may have been affected by cystectomy and urinary diversion, and that could then be used to form a basis for a diversion-specific HRQOL measure.
Results: The average age of neo-bladder patients was 59 versus 65 years for ileal conduit patients. We identified More >

Glenn Bauman¹, Eric Winquist², Joseph Chin³

Canadian Journal of Urology, Vol.12, No.1, pp. 2532-2536, 2005

Abstract A successful pilot study of a videoconferenced multidisciplinary genitourinary tumor board involving 21 physicians over six geographic sites for a 6-month period is reported. The majority of cases presented at the tumor board were of prostate or bladder origin. Specific recommendations around management, patient referral or clinical trial eligibility were made in the majority of cases presented. Physician satisfaction with the rounds was high and participation beyond the pilot has continued. Scheduling in order to provide maximum access/participation has been the main logistical challenge with the rounds. More >

Himu Lukka¹, Tom Pickles², Gerard Morton³, Charles Catton⁴, Luis Souhami⁵, Padraig Warde⁴

Canadian Journal of Urology, Vol.12, No.1, pp. 2521-2531, 2005

Abstract In November 2000, the GU Radiation Oncologists of Canada had their first meeting, “Controversies in prostate cancer radiotherapy: consensus development”. The success of this meeting prompted a second meeting, held in December 2002 to discuss “The Way Forward” in prostate radiotherapy. Radiation oncologists from across Canada were brought together and integrated with key opinion leaders in prostate cancer treatment from throughout North America. The group debated current controversies including: intensity modulated radiotherapy (IMRT), external beam hypofractionation, high dose-rate brachytherapy, and hormone therapy in the management of prostate cancer. The meeting also sought to identify and… More >

William A. Gourlay¹, Lynn Stothers², Li Liu^1,3

Canadian Journal of Urology, Vol.12, No.1, pp. 2511-2520, 2005

Abstract Introduction: Live donor kidney transplantation (LDKT) is both medically and economically superior to cadaver kidney transplantation in the treatment of patients with chronic renal failure. Unfortunately, fewer than 50% of patients on the transplant waiting list have a relative or friend who contacts the transplant program about possible donation. We hypothesized that both the potential recipient and potential donor have identifiable and modifiable characteristics that contribute to the likelihood of a live donor transplant.
Materials and methods: Specifically-designed and validated questionnaires addressing personal characteristics, knowledge and beliefs about LDKT were mailed to patients who had previously received… More >

H. McDonald, M. Hux, M. Brisson, L. Bernard, J.C. Nickel

Canadian Journal of Urology, Vol.12, No.1, pp. 2508-2510, 2005

Abstract This article has no abstract. More >

Joseph L. Chin

Canadian Journal of Urology, Vol.12, No.1, pp. 2507-2507, 2005

Abstract This article has no abstract. More >